📰 Standard Biotools News
Page 3 - Standard Biotools News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Standard Biotools. Real-time updates on events, politics, business and more.
January 24, 2024
As science continues to uncover the mysteries of aging, we are left with the question of why we age — a question to which there might be no answer.
January 12, 2024
Freedom Wealth Alliance LLC purchased a new position in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 20,394 shares of the company’s stock, valued at approximately $59,000. A number of other hedge funds have […]
January 6, 2024
SomaLogic Inc. (Nasdaq: SLGC) said Thursday evening that its $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB) is expected to be finalized Friday after shareholders for the Boulder biotech company voted this week to consummate the combination.
January 5, 2024
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to...
January 5, 2024
Believes All SomaLogic Directors – Robert Barchi, Thomas Carey, Eli Casdin, Troy Cox, Kathy Hibbs, Anne Margulies, Tycho Peterson, Richard Post and Jason Ryan – Have Betrayed Shareholders by...
January 5, 2024
Stockholder Approval Represents Key Milestone Toward Completion of Standard BioTools Transaction Combination Will Create a Diversified Leader in Life Sciences Tools BOULDER, Colo., Jan. 4, 2024...
January 4, 2024
M&A activity in 2023 was subdued, as dealmakers grappled with geopolitical tensions, inflation, rising interest rates, and increasing regulatory scrutiny, against a backdrop of general...
January 4, 2024
Believes Two Last-Minute Adjournments of Special Meeting Stem From Fellow Shareholders Recognizing the Deal Consideration Assigns No Value to SomaLogic’s Desirable Assets and Represents a Material...
January 3, 2024
Madryn Asset Management, LP, a shareholder of around 4.2 percent common stock in pharma firm SomaLogic, Inc. (SLGC) said on Wednesday that Egan-Jones Proxy Services has recommended shareholders to vote against the merger with Standard BioTools Inc.